Macrobid vs Bactrim for UTI: Which Is Better?
If you've ever been prescribed an antibiotic for a urinary tract infection, it was probably one of two names: Macrobid (nitrofurantoin) or Bactrim (trimethoprim-sulfamethoxazole). Together they account for the majority of outpatient UTI prescriptions in the United States. But which one is actually better? The honest answer — like most things in medicine — is "it depends." Below, we break down how the two compare on efficacy, resistance, side effects, and the clinical scenarios where one clearly wins.
The Quick Answer
For most uncomplicated lower UTIs in otherwise healthy adults, current guidelines from the Infectious Diseases Society of America (IDSA) and the American Urological Association now list nitrofurantoin (Macrobid) as a first-line choice — a change driven almost entirely by rising resistance to Bactrim. In regions where local E. coli resistance to trimethoprim-sulfamethoxazole is above 20%, empiric use of Bactrim is discouraged. Most of the continental United States has now crossed that threshold.
That said, Bactrim still has a place. It is cheaper, dosed twice daily for only three days, and it works well in kidney infections (pyelonephritis) where Macrobid does not. So the better question isn't "which drug is stronger" — it's "which drug is right for this infection in this person?"
How Each Antibiotic Works
Macrobid (nitrofurantoin)
Nitrofurantoin is unusual: after you swallow it, the drug is rapidly filtered by the kidneys and concentrates in the urine at levels far higher than anywhere else in the body. That's a feature, not a bug — it means Macrobid delivers a powerful punch right where UTI bacteria live (the bladder lining) while leaving systemic tissues mostly untouched. It's been in clinical use since 1953, and despite seven decades of exposure, E. coli resistance has remained remarkably low — under 5% in most U.S. surveillance data.
The standard adult dose is 100 mg twice daily for 5 days. Food helps absorption and reduces nausea, so take it with a meal.
Bactrim (trimethoprim-sulfamethoxazole)
Bactrim is a combination of two antibiotics that block sequential steps in the folate pathway that bacteria need to make DNA. It spreads throughout the body — bladder, kidneys, prostate, skin, lungs. That broader distribution makes it versatile (it's also used for MRSA skin infections, certain pneumonias, and travelers' diarrhea), but it also means higher exposure for your gut flora and more opportunities for resistance to develop.
For uncomplicated UTI, the dose is one double-strength (DS) tablet twice daily for 3 days.
Efficacy and Cure Rates
Head-to-head trials have generally found the two drugs roughly equivalent for uncomplicated cystitis — when the bacteria are susceptible. A 2012 randomized trial in JAMA Internal Medicine compared 5 days of nitrofurantoin to 3 days of trimethoprim-sulfamethoxazole and found clinical cure rates of 84% versus 79% respectively, with microbiological cure rates similarly close. The catch is that word "susceptible." If the bug is resistant to your drug, the cure rate collapses.
"In settings where the prevalence of resistance to trimethoprim-sulfamethoxazole exceeds 20%, alternative agents should be considered for empiric therapy of uncomplicated UTI."— IDSA Guidelines, updated 2023
Resistance: The Real Differentiator
This is where the two drugs have genuinely diverged. The 2024 SENTRY surveillance data, published in The Lancet Infectious Diseases, reported U.S. E. coli urinary isolate resistance rates of approximately:
- Nitrofurantoin (Macrobid): 2 to 5 percent
- Trimethoprim-sulfamethoxazole (Bactrim): 22 to 30 percent, with some regions above 35 percent
- Ciprofloxacin: 14 to 20 percent
That doesn't mean Bactrim is useless — it means blindly prescribing it empirically (without a culture) increasingly results in treatment failure. If a urine culture comes back sensitive to Bactrim, it's still a perfectly reasonable choice.
Side Effects Compared
| Side effect | Macrobid | Bactrim |
|---|---|---|
| Nausea / GI upset | Common (~8%) | Common (~5%) |
| Headache | Common | Occasional |
| Rash | Uncommon | Common; rarely severe (SJS) |
| Photosensitivity | No | Yes |
| Pulmonary reactions | Rare, mostly long-term use | No |
| Hyperkalemia | No | Possible, esp. with ACE inhibitors |
| Sulfa allergy concern | No | Contraindicated |
When Macrobid Clearly Wins
- Uncomplicated lower UTI in a non-pregnant adult with normal kidney function
- You have a sulfa allergy
- You're on warfarin (Bactrim can dangerously raise INR)
- You live in a region with high Bactrim resistance
- You're early-to-mid pregnancy (Macrobid is Category B; Bactrim carries folate-related concerns)
When Bactrim Is the Better Choice
- Suspected or confirmed kidney infection (pyelonephritis) — Macrobid doesn't reach kidney tissue adequately
- A culture shows the bug is sensitive to Bactrim and resistant to nitrofurantoin
- You have significantly reduced kidney function (CrCl < 30 mL/min), where Macrobid is not recommended because it can't concentrate in urine
- Cost is the deciding factor — Bactrim is generally a few dollars cheaper
What Bidwell Providers Actually Prescribe
Most Bidwell visits for uncomplicated UTI result in a 5-day course of Macrobid, unless the patient has a contraindication or a history of culture-confirmed resistance. We follow CDC antibiotic stewardship guidance: narrow-spectrum first, match to local resistance patterns, and escalate only when needed. If your symptoms suggest anything beyond a simple bladder infection — flank pain, fever, vomiting, or pregnancy — a telehealth provider will direct you to in-person care where a urine culture and sometimes IV antibiotics are warranted.
Related reading on Bidwell:
- UTIs in 2026: What the latest research means for you
- Can you get a UTI prescription without seeing a doctor?
- How much does online UTI treatment cost?
- UTI symptoms but negative urine test: what now?
State-specific resources: Florida · New York · Arizona · Washington.